Post date March 8, 2024 Experience LivaNova $345 million convertible notes offering and capped call transactions The 2.5% convertible senior notes are due 2029
Post date February 5, 2024 Experience Immunocore Holdings $402.5 million convertible notes offering The 2.5% convertible notes are due 2030
Post date September 14, 2023 Experience Arm $4.87 billion IPO The deal is the largest U.S. IPO since November 2021
Post date September 9, 2022 Experience Immunocore $250 million at-the-market offering The ADSs are listed on the Nasdaq Global Market
Post date August 10, 2022 Experience Vaccitech $75 million at-the-market offering The ADSs are listed on the Nasdaq Global Market
Post date March 16, 2022 Experience New Energy One Acquisition £175 million IPO Shares of the SPAC are listed on the London Stock Exchange
Post date August 6, 2021 Experience LivaNova $345 million equity offering We advised the underwriters on the SEC-registered offering
Post date July 26, 2021 Experience Royalty Pharma $1.3 billion senior notes offering We advised Royalty Pharma on its SEC-registered investment-grade notes offering, including $600 million in social bonds
Post date July 20, 2021 Experience Sixjoy Hong Kong £919 million offer for Sumo Group We are advising Tencent on the recommended cash offer by its indirect subsidiary
Post date July 19, 2021 Experience Membership Collective Group $420 million IPO We advised the underwriters on the IPO and NYSE listing